1 Study Coverage
    1.1 Neuropeptide Y Receptor Product Introduction
    1.2 Market by Type
        1.2.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Food Grade
        1.2.3 Pharmaceutical Grade
    1.3 Market by Application
        1.3.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Medicine
        1.3.3 Food Additives
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Neuropeptide Y Receptor Sales Estimates and Forecasts 2017-2028
    2.2 Global Neuropeptide Y Receptor Revenue Estimates and Forecasts 2017-2028
    2.3 Global Neuropeptide Y Receptor Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Neuropeptide Y Receptor Sales by Region
        2.4.1 Global Neuropeptide Y Receptor Sales by Region (2017-2022)
        2.4.2 Global Sales Neuropeptide Y Receptor by Region (2023-2028)
    2.5 Global Neuropeptide Y Receptor Revenue by Region
        2.5.1 Global Neuropeptide Y Receptor Revenue by Region (2017-2022)
        2.5.2 Global Neuropeptide Y Receptor Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Neuropeptide Y Receptor Sales by Manufacturers
        3.1.1 Global Top Neuropeptide Y Receptor Manufacturers by Sales (2017-2022)
        3.1.2 Global Neuropeptide Y Receptor Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neuropeptide Y Receptor in 2021
    3.2 Global Neuropeptide Y Receptor Revenue by Manufacturers
        3.2.1 Global Neuropeptide Y Receptor Revenue by Manufacturers (2017-2022)
        3.2.2 Global Neuropeptide Y Receptor Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Neuropeptide Y Receptor Revenue in 2021
    3.3 Global Neuropeptide Y Receptor Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Neuropeptide Y Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Neuropeptide Y Receptor Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Neuropeptide Y Receptor Sales by Type
        4.1.1 Global Neuropeptide Y Receptor Historical Sales by Type (2017-2022)
        4.1.2 Global Neuropeptide Y Receptor Forecasted Sales by Type (2023-2028)
        4.1.3 Global Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    4.2 Global Neuropeptide Y Receptor Revenue by Type
        4.2.1 Global Neuropeptide Y Receptor Historical Revenue by Type (2017-2022)
        4.2.2 Global Neuropeptide Y Receptor Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    4.3 Global Neuropeptide Y Receptor Price by Type
        4.3.1 Global Neuropeptide Y Receptor Price by Type (2017-2022)
        4.3.2 Global Neuropeptide Y Receptor Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Neuropeptide Y Receptor Sales by Application
        5.1.1 Global Neuropeptide Y Receptor Historical Sales by Application (2017-2022)
        5.1.2 Global Neuropeptide Y Receptor Forecasted Sales by Application (2023-2028)
        5.1.3 Global Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    5.2 Global Neuropeptide Y Receptor Revenue by Application
        5.2.1 Global Neuropeptide Y Receptor Historical Revenue by Application (2017-2022)
        5.2.2 Global Neuropeptide Y Receptor Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    5.3 Global Neuropeptide Y Receptor Price by Application
        5.3.1 Global Neuropeptide Y Receptor Price by Application (2017-2022)
        5.3.2 Global Neuropeptide Y Receptor Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Neuropeptide Y Receptor Market Size by Type
        6.1.1 North America Neuropeptide Y Receptor Sales by Type (2017-2028)
        6.1.2 North America Neuropeptide Y Receptor Revenue by Type (2017-2028)
    6.2 North America Neuropeptide Y Receptor Market Size by Application
        6.2.1 North America Neuropeptide Y Receptor Sales by Application (2017-2028)
        6.2.2 North America Neuropeptide Y Receptor Revenue by Application (2017-2028)
    6.3 North America Neuropeptide Y Receptor Market Size by Country
        6.3.1 North America Neuropeptide Y Receptor Sales by Country (2017-2028)
        6.3.2 North America Neuropeptide Y Receptor Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Neuropeptide Y Receptor Market Size by Type
        7.1.1 Europe Neuropeptide Y Receptor Sales by Type (2017-2028)
        7.1.2 Europe Neuropeptide Y Receptor Revenue by Type (2017-2028)
    7.2 Europe Neuropeptide Y Receptor Market Size by Application
        7.2.1 Europe Neuropeptide Y Receptor Sales by Application (2017-2028)
        7.2.2 Europe Neuropeptide Y Receptor Revenue by Application (2017-2028)
    7.3 Europe Neuropeptide Y Receptor Market Size by Country
        7.3.1 Europe Neuropeptide Y Receptor Sales by Country (2017-2028)
        7.3.2 Europe Neuropeptide Y Receptor Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Neuropeptide Y Receptor Market Size by Type
        8.1.1 Asia Pacific Neuropeptide Y Receptor Sales by Type (2017-2028)
        8.1.2 Asia Pacific Neuropeptide Y Receptor Revenue by Type (2017-2028)
    8.2 Asia Pacific Neuropeptide Y Receptor Market Size by Application
        8.2.1 Asia Pacific Neuropeptide Y Receptor Sales by Application (2017-2028)
        8.2.2 Asia Pacific Neuropeptide Y Receptor Revenue by Application (2017-2028)
    8.3 Asia Pacific Neuropeptide Y Receptor Market Size by Region
        8.3.1 Asia Pacific Neuropeptide Y Receptor Sales by Region (2017-2028)
        8.3.2 Asia Pacific Neuropeptide Y Receptor Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Neuropeptide Y Receptor Market Size by Type
        9.1.1 Latin America Neuropeptide Y Receptor Sales by Type (2017-2028)
        9.1.2 Latin America Neuropeptide Y Receptor Revenue by Type (2017-2028)
    9.2 Latin America Neuropeptide Y Receptor Market Size by Application
        9.2.1 Latin America Neuropeptide Y Receptor Sales by Application (2017-2028)
        9.2.2 Latin America Neuropeptide Y Receptor Revenue by Application (2017-2028)
    9.3 Latin America Neuropeptide Y Receptor Market Size by Country
        9.3.1 Latin America Neuropeptide Y Receptor Sales by Country (2017-2028)
        9.3.2 Latin America Neuropeptide Y Receptor Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Neuropeptide Y Receptor Market Size by Type
        10.1.1 Middle East and Africa Neuropeptide Y Receptor Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Type (2017-2028)
    10.2 Middle East and Africa Neuropeptide Y Receptor Market Size by Application
        10.2.1 Middle East and Africa Neuropeptide Y Receptor Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Application (2017-2028)
    10.3 Middle East and Africa Neuropeptide Y Receptor Market Size by Country
        10.3.1 Middle East and Africa Neuropeptide Y Receptor Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Gila Therapeutics
        11.1.1 Gila Therapeutics Corporation Information
        11.1.2 Gila Therapeutics Overview
        11.1.3 Gila Therapeutics Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Gila Therapeutics Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Gila Therapeutics Recent Developments
    11.2 Novo Nordisk
        11.2.1 Novo Nordisk Corporation Information
        11.2.2 Novo Nordisk Overview
        11.2.3 Novo Nordisk Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novo Nordisk Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novo Nordisk Recent Developments
    11.3 XL-protein
        11.3.1 XL-protein Corporation Information
        11.3.2 XL-protein Overview
        11.3.3 XL-protein Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 XL-protein Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 XL-protein Recent Developments
    11.4 Lilly Eli
        11.4.1 Lilly Eli Corporation Information
        11.4.2 Lilly Eli Overview
        11.4.3 Lilly Eli Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Lilly Eli Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Lilly Eli Recent Developments
    11.5 Novartis
        11.5.1 Novartis Corporation Information
        11.5.2 Novartis Overview
        11.5.3 Novartis Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Novartis Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Novartis Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Merck & Co
        11.7.1 Merck & Co Corporation Information
        11.7.2 Merck & Co Overview
        11.7.3 Merck & Co Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Merck & Co Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Merck & Co Recent Developments
    11.8 Mannkind
        11.8.1 Mannkind Corporation Information
        11.8.2 Mannkind Overview
        11.8.3 Mannkind Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Mannkind Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Mannkind Recent Developments
    11.9 Gilead Sciences
        11.9.1 Gilead Sciences Corporation Information
        11.9.2 Gilead Sciences Overview
        11.9.3 Gilead Sciences Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Gilead Sciences Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Gilead Sciences Recent Developments
    11.10 Genentech
        11.10.1 Genentech Corporation Information
        11.10.2 Genentech Overview
        11.10.3 Genentech Neuropeptide Y Receptor Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Genentech Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Genentech Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Neuropeptide Y Receptor Industry Chain Analysis
    12.2 Neuropeptide Y Receptor Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Neuropeptide Y Receptor Production Mode & Process
    12.4 Neuropeptide Y Receptor Sales and Marketing
        12.4.1 Neuropeptide Y Receptor Sales Channels
        12.4.2 Neuropeptide Y Receptor Distributors
    12.5 Neuropeptide Y Receptor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Neuropeptide Y Receptor Industry Trends
    13.2 Neuropeptide Y Receptor Market Drivers
    13.3 Neuropeptide Y Receptor Market Challenges
    13.4 Neuropeptide Y Receptor Market Restraints
14 Key Findings in The Global Neuropeptide Y Receptor Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Neuropeptide Y Receptor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Food Grade
    Table 3. Major Manufacturers of Pharmaceutical Grade
    Table 4. Global Neuropeptide Y Receptor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Neuropeptide Y Receptor Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Neuropeptide Y Receptor Sales by Region (2017-2022) & (Kiloton)
    Table 7. Global Neuropeptide Y Receptor Sales Market Share by Region (2017-2022)
    Table 8. Global Neuropeptide Y Receptor Sales by Region (2023-2028) & (Kiloton)
    Table 9. Global Neuropeptide Y Receptor Sales Market Share by Region (2023-2028)
    Table 10. Global Neuropeptide Y Receptor Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Neuropeptide Y Receptor Revenue Market Share by Region (2017-2022)
    Table 12. Global Neuropeptide Y Receptor Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Neuropeptide Y Receptor Revenue Market Share by Region (2023-2028)
    Table 14. Global Neuropeptide Y Receptor Sales by Manufacturers (2017-2022) & (Kiloton)
    Table 15. Global Neuropeptide Y Receptor Sales Share by Manufacturers (2017-2022)
    Table 16. Global Neuropeptide Y Receptor Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Neuropeptide Y Receptor Revenue Share by Manufacturers (2017-2022)
    Table 18. Neuropeptide Y Receptor Price by Manufacturers (2017-2022) &(US$/Ton)
    Table 19. Global Neuropeptide Y Receptor Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Neuropeptide Y Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuropeptide Y Receptor as of 2021)
    Table 21. Neuropeptide Y Receptor Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Neuropeptide Y Receptor Product Offered
    Table 23. Date of Manufacturers Enter into Neuropeptide Y Receptor Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
    Table 26. Global Neuropeptide Y Receptor Sales by Type (2023-2028) & (Kiloton)
    Table 27. Global Neuropeptide Y Receptor Sales Share by Type (2017-2022)
    Table 28. Global Neuropeptide Y Receptor Sales Share by Type (2023-2028)
    Table 29. Global Neuropeptide Y Receptor Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Neuropeptide Y Receptor Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Neuropeptide Y Receptor Revenue Share by Type (2017-2022)
    Table 32. Global Neuropeptide Y Receptor Revenue Share by Type (2023-2028)
    Table 33. Neuropeptide Y Receptor Price by Type (2017-2022) & (US$/Ton)
    Table 34. Global Neuropeptide Y Receptor Price Forecast by Type (2023-2028) & (US$/Ton)
    Table 35. Global Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
    Table 36. Global Neuropeptide Y Receptor Sales by Application (2023-2028) & (Kiloton)
    Table 37. Global Neuropeptide Y Receptor Sales Share by Application (2017-2022)
    Table 38. Global Neuropeptide Y Receptor Sales Share by Application (2023-2028)
    Table 39. Global Neuropeptide Y Receptor Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Neuropeptide Y Receptor Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Neuropeptide Y Receptor Revenue Share by Application (2017-2022)
    Table 42. Global Neuropeptide Y Receptor Revenue Share by Application (2023-2028)
    Table 43. Neuropeptide Y Receptor Price by Application (2017-2022) & (US$/Ton)
    Table 44. Global Neuropeptide Y Receptor Price Forecast by Application (2023-2028) & (US$/Ton)
    Table 45. North America Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
    Table 46. North America Neuropeptide Y Receptor Sales by Type (2023-2028) & (Kiloton)
    Table 47. North America Neuropeptide Y Receptor Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Neuropeptide Y Receptor Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
    Table 50. North America Neuropeptide Y Receptor Sales by Application (2023-2028) & (Kiloton)
    Table 51. North America Neuropeptide Y Receptor Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Neuropeptide Y Receptor Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
    Table 54. North America Neuropeptide Y Receptor Sales by Country (2023-2028) & (Kiloton)
    Table 55. North America Neuropeptide Y Receptor Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Neuropeptide Y Receptor Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
    Table 58. Europe Neuropeptide Y Receptor Sales by Type (2023-2028) & (Kiloton)
    Table 59. Europe Neuropeptide Y Receptor Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Neuropeptide Y Receptor Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
    Table 62. Europe Neuropeptide Y Receptor Sales by Application (2023-2028) & (Kiloton)
    Table 63. Europe Neuropeptide Y Receptor Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Neuropeptide Y Receptor Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
    Table 66. Europe Neuropeptide Y Receptor Sales by Country (2023-2028) & (Kiloton)
    Table 67. Europe Neuropeptide Y Receptor Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Neuropeptide Y Receptor Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
    Table 70. Asia Pacific Neuropeptide Y Receptor Sales by Type (2023-2028) & (Kiloton)
    Table 71. Asia Pacific Neuropeptide Y Receptor Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Neuropeptide Y Receptor Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
    Table 74. Asia Pacific Neuropeptide Y Receptor Sales by Application (2023-2028) & (Kiloton)
    Table 75. Asia Pacific Neuropeptide Y Receptor Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Neuropeptide Y Receptor Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Neuropeptide Y Receptor Sales by Region (2017-2022) & (Kiloton)
    Table 78. Asia Pacific Neuropeptide Y Receptor Sales by Region (2023-2028) & (Kiloton)
    Table 79. Asia Pacific Neuropeptide Y Receptor Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Neuropeptide Y Receptor Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
    Table 82. Latin America Neuropeptide Y Receptor Sales by Type (2023-2028) & (Kiloton)
    Table 83. Latin America Neuropeptide Y Receptor Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Neuropeptide Y Receptor Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
    Table 86. Latin America Neuropeptide Y Receptor Sales by Application (2023-2028) & (Kiloton)
    Table 87. Latin America Neuropeptide Y Receptor Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Neuropeptide Y Receptor Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
    Table 90. Latin America Neuropeptide Y Receptor Sales by Country (2023-2028) & (Kiloton)
    Table 91. Latin America Neuropeptide Y Receptor Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Neuropeptide Y Receptor Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Neuropeptide Y Receptor Sales by Type (2017-2022) & (Kiloton)
    Table 94. Middle East and Africa Neuropeptide Y Receptor Sales by Type (2023-2028) & (Kiloton)
    Table 95. Middle East and Africa Neuropeptide Y Receptor Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Neuropeptide Y Receptor Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Neuropeptide Y Receptor Sales by Application (2017-2022) & (Kiloton)
    Table 98. Middle East and Africa Neuropeptide Y Receptor Sales by Application (2023-2028) & (Kiloton)
    Table 99. Middle East and Africa Neuropeptide Y Receptor Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Neuropeptide Y Receptor Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Neuropeptide Y Receptor Sales by Country (2017-2022) & (Kiloton)
    Table 102. Middle East and Africa Neuropeptide Y Receptor Sales by Country (2023-2028) & (Kiloton)
    Table 103. Middle East and Africa Neuropeptide Y Receptor Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Neuropeptide Y Receptor Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Gila Therapeutics Corporation Information
    Table 106. Gila Therapeutics Description and Major Businesses
    Table 107. Gila Therapeutics Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 108. Gila Therapeutics Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Gila Therapeutics Recent Developments
    Table 110. Novo Nordisk Corporation Information
    Table 111. Novo Nordisk Description and Major Businesses
    Table 112. Novo Nordisk Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 113. Novo Nordisk Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Novo Nordisk Recent Developments
    Table 115. XL-protein Corporation Information
    Table 116. XL-protein Description and Major Businesses
    Table 117. XL-protein Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 118. XL-protein Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. XL-protein Recent Developments
    Table 120. Lilly Eli Corporation Information
    Table 121. Lilly Eli Description and Major Businesses
    Table 122. Lilly Eli Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 123. Lilly Eli Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Lilly Eli Recent Developments
    Table 125. Novartis Corporation Information
    Table 126. Novartis Description and Major Businesses
    Table 127. Novartis Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 128. Novartis Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Novartis Recent Developments
    Table 130. Pfizer Corporation Information
    Table 131. Pfizer Description and Major Businesses
    Table 132. Pfizer Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 133. Pfizer Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Pfizer Recent Developments
    Table 135. Merck & Co Corporation Information
    Table 136. Merck & Co Description and Major Businesses
    Table 137. Merck & Co Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 138. Merck & Co Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Merck & Co Recent Developments
    Table 140. Mannkind Corporation Information
    Table 141. Mannkind Description and Major Businesses
    Table 142. Mannkind Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 143. Mannkind Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Mannkind Recent Developments
    Table 145. Gilead Sciences Corporation Information
    Table 146. Gilead Sciences Description and Major Businesses
    Table 147. Gilead Sciences Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 148. Gilead Sciences Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Gilead Sciences Recent Developments
    Table 150. Genentech Corporation Information
    Table 151. Genentech Description and Major Businesses
    Table 152. Genentech Neuropeptide Y Receptor Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 153. Genentech Neuropeptide Y Receptor Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Genentech Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Neuropeptide Y Receptor Distributors List
    Table 158. Neuropeptide Y Receptor Customers List
    Table 159. Neuropeptide Y Receptor Market Trends
    Table 160. Neuropeptide Y Receptor Market Drivers
    Table 161. Neuropeptide Y Receptor Market Challenges
    Table 162. Neuropeptide Y Receptor Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuropeptide Y Receptor Product Picture
    Figure 3. Global Neuropeptide Y Receptor Market Share by Type in 2021 & 2028
    Figure 3. Food Grade Product Picture
    Figure 4. Pharmaceutical Grade Product Picture
    Figure 5. Global Neuropeptide Y Receptor Market Share by Application in 2021 & 2028
    Figure 6. Medicine
    Figure 7. Food Additives
    Figure 8. Others
    Figure 9. Neuropeptide Y Receptor Report Years Considered
    Figure 10. Global Neuropeptide Y Receptor Sales 2017-2028 (Kiloton)
    Figure 11. Global Neuropeptide Y Receptor Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Neuropeptide Y Receptor Revenue 2017-2028 (US$ Million)
    Figure 13. Global Neuropeptide Y Receptor Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Neuropeptide Y Receptor Sales Market Share by Region (2017-2022)
    Figure 15. Global Neuropeptide Y Receptor Sales Market Share by Region (2023-2028)
    Figure 16. North America Neuropeptide Y Receptor Sales YoY (2017-2028) & (Kiloton)
    Figure 17. North America Neuropeptide Y Receptor Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Neuropeptide Y Receptor Sales YoY (2017-2028) & (Kiloton)
    Figure 19. Europe Neuropeptide Y Receptor Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Neuropeptide Y Receptor Sales YoY (2017-2028) & (Kiloton)
    Figure 21. Asia-Pacific Neuropeptide Y Receptor Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Neuropeptide Y Receptor Sales YoY (2017-2028) & (Kiloton)
    Figure 23. Latin America Neuropeptide Y Receptor Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Neuropeptide Y Receptor Sales YoY (2017-2028) & (Kiloton)
    Figure 25. Middle East & Africa Neuropeptide Y Receptor Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Neuropeptide Y Receptor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Neuropeptide Y Receptor in the World: Market Share by Neuropeptide Y Receptor Revenue in 2021
    Figure 28. Global Neuropeptide Y Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    Figure 30. Global Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    Figure 31. Global Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    Figure 32. Global Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    Figure 33. North America Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    Figure 34. North America Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    Figure 35. North America Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    Figure 36. North America Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    Figure 37. North America Neuropeptide Y Receptor Sales Share by Country (2017-2028)
    Figure 38. North America Neuropeptide Y Receptor Revenue Share by Country (2017-2028)
    Figure 39. U.S. Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    Figure 42. Europe Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    Figure 44. Europe Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Neuropeptide Y Receptor Sales Share by Country (2017-2028)
    Figure 46. Europe Neuropeptide Y Receptor Revenue Share by Country (2017-2028)
    Figure 47. Germany Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 48. France Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Neuropeptide Y Receptor Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Neuropeptide Y Receptor Revenue Share by Region (2017-2028)
    Figure 58. China Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 61. India Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Neuropeptide Y Receptor Sales Share by Country (2017-2028)
    Figure 73. Latin America Neuropeptide Y Receptor Revenue Share by Country (2017-2028)
    Figure 74. Mexico Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Neuropeptide Y Receptor Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Neuropeptide Y Receptor Revenue Share by Country (2017-2028)
    Figure 83. Turkey Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Neuropeptide Y Receptor Revenue (2017-2028) & (US$ Million)
    Figure 86. Neuropeptide Y Receptor Value Chain
    Figure 87. Neuropeptide Y Receptor Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed